Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Risankizumab-rzaa 60 Mg/ml Intravenous Solution (CPT 74501) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/74501/by-state?code_type=CPT
“Risankizumab-rzaa 60 Mg/ml Intravenous Solution (CPT 74501) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/74501/by-state?code_type=CPT. Accessed
June 28, 2026 .
“Risankizumab-rzaa 60 Mg/ml Intravenous Solution (CPT 74501) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/74501/by-state?code_type=CPT.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CPT · across United States
74501 — Risankizumab-rzaa 60 Mg/ml Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$25,502
National median
$20,389 – $37,003
IQR (p25 – p75)
3
hospitals filing
3
states
Walking in without insurance?
Cash / self-pay price
Cash median
$29,145
vs. negotiated
+14.3%
Hospitals reporting
3
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 74501 (CPT), with interquartile range
State Median p25 p75
KS $43,170 $41,270 $48,104
TX $26,412 $25,502 $28,690
NE $20,389 $20,174 $20,604